These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 27696190

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Low Concentrations of Recombinant Factor VIIa May Improve the Impaired Thrombin Generation of Glanzmann Thrombasthenia Patients.
    Levy-Mendelovich S, Levy T, Budnik I, Barg AA, Rosenberg N, Seligsohn U, Kenet G, Livnat T.
    Thromb Haemost; 2019 Jan; 119(1):117-127. PubMed ID: 30597506
    [Abstract] [Full Text] [Related]

  • 5. Intensive menstrual bleeding successfully treated with recombinant factor VIIa in Glanzmann thrombasthenia.
    Balci YI, Karabulut A, Kabukcu S, Sari I, Keskin A.
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):320-2. PubMed ID: 20460355
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Targeting tissue factor pathway inhibitor with concizumab to improve hemostasis in patients with Glanzmann thrombasthenia: an in vitro study.
    Dubut J, Goin V, Derray C, Huguenin Y, Fiore M.
    J Thromb Haemost; 2024 Sep; 22(9):2589-2600. PubMed ID: 38880178
    [Abstract] [Full Text] [Related]

  • 12. Use of rFVIIa in 4 children with Glanzmann thrombasthenia.
    Valentino LA.
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):653-8. PubMed ID: 17023825
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anti-αIIb β3 immunization in Glanzmann thrombasthenia: review of literature and treatment recommendations.
    Fiore M, d'Oiron R, Pillois X, Alessi MC.
    Br J Haematol; 2018 Apr; 181(2):173-182. PubMed ID: 29611179
    [Abstract] [Full Text] [Related]

  • 15. Perioperative management of a pediatric patient with Glanzmann's thrombasthenia during adenoidectomy.
    Duman EN, Saylan S, Cekic B.
    Rev Bras Anestesiol; 2012 Jul; 62(4):548-53. PubMed ID: 22793971
    [Abstract] [Full Text] [Related]

  • 16. The use of recombinant factor VIla in a primigravida with Glanzmann's thrombasthenia during delivery.
    Kale A, Bayhan G, Yalinkaya A, Yayla M.
    J Perinat Med; 2004 Jul; 32(5):456-8. PubMed ID: 15493726
    [Abstract] [Full Text] [Related]

  • 17. Molecular analysis of a patient with type I Glanzmann thrombasthenia and clinical impact of the presence of anti-αIIbβ3 alloantibodies.
    Kashiwagi H, Kiyomizu K, Kamae T, Nakazawa T, Tadokoro S, Takiguchi S, Doki Y, Kanakura Y, Tomiyama Y.
    Int J Hematol; 2011 Jan; 93(1):106-11. PubMed ID: 21136216
    [Abstract] [Full Text] [Related]

  • 18. Weekly low-dose recombinant factor VIIa prophylaxis in Glanzmann thrombasthenia.
    Andiç N, Oğuz N, Gündüz E, Kiraz Bulduk T, Üsküdar Teke H.
    Blood Coagul Fibrinolysis; 2021 Jul 01; 32(5):349-351. PubMed ID: 33878047
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Open aortic valve replacement in a patient with Glanzmann's thrombasthenia: a multidisciplinary strategy to minimize perioperative bleeding.
    Sheikh AY, Hill CC, Goodnough LT, Leung LL, Fischbein MP.
    Transfusion; 2014 Feb 01; 54(2):300-5. PubMed ID: 23710629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.